BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19842032)

  • 1. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.
    Herynk MH; Hopp T; Cui Y; Niu A; Corona-Rodriguez A; Fuqua SA
    Breast Cancer Res Treat; 2010 Jul; 122(2):381-93. PubMed ID: 19842032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.
    Herynk MH; Lewis MT; Hopp TA; Medina D; Corona-Rodriguez A; Cui Y; Beyer AR; Fuqua SA
    Oncogene; 2009 Sep; 28(36):3177-87. PubMed ID: 19561644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.
    Kalet BT; Anglin SR; Handschy A; O'Donoghue LE; Halsey C; Chubb L; Korch C; Duval DL
    PLoS One; 2013; 8(7):e68815. PubMed ID: 23874775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells.
    Meneses-Morales I; Tecalco-Cruz AC; Barrios-García T; Gómez-Romero V; Trujillo-González I; Reyes-Carmona S; García-Zepeda E; Méndez-Enríquez E; Cervantes-Roldán R; Pérez-Sánchez V; Recillas-Targa F; Mohar-Betancourt A; León-Del-Río A
    Nucleic Acids Res; 2014 Jun; 42(11):6885-900. PubMed ID: 24771346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor.
    Zheng L; Annab LA; Afshari CA; Lee WH; Boyer TG
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9587-92. PubMed ID: 11493692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.
    Nichols M; Cheng P; Liu Y; Kanterewicz B; Hershberger PA; McCarty KS
    Breast Cancer Res Treat; 2010 Apr; 120(3):761-8. PubMed ID: 19526339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.
    Barone I; Cui Y; Herynk MH; Corona-Rodriguez A; Giordano C; Selever J; Beyer A; Andò S; Fuqua SA
    Cancer Res; 2009 Jun; 69(11):4724-32. PubMed ID: 19487288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tristetraprolin represses estrogen receptor α transactivation in breast cancer cells.
    Barrios-García T; Tecalco-Cruz A; Gómez-Romero V; Reyes-Carmona S; Meneses-Morales I; León-Del-Río A
    J Biol Chem; 2014 May; 289(22):15554-65. PubMed ID: 24737323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.
    Karmakar S; Foster EA; Smith CL
    Endocrinology; 2009 Apr; 150(4):1588-96. PubMed ID: 19095746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening.
    Nakadai T; Yang L; Kumegawa K; Maruyama R
    Mol Biol Rep; 2023 Feb; 50(2):1209-1220. PubMed ID: 36436079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J; Wihlén B; Thomsen J; Gustafsson JA
    Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.
    Herynk MH; Beyer AR; Cui Y; Weiss H; Anderson E; Green TP; Fuqua SA
    Mol Cancer Ther; 2006 Dec; 5(12):3023-31. PubMed ID: 17172405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.
    Gong EY; Park E; Lee K
    Cancer Sci; 2010 Sep; 101(9):2019-25. PubMed ID: 20608937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
    Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
    Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
    Stoica A; Pentecost E; Martin MB
    Endocrinology; 2000 Oct; 141(10):3595-602. PubMed ID: 11014213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.